Source: Nextech AR Solutions.
  • Nextech AR Solutions (NTAR) signs contract to supply Majid Al Futtaim with thousands of 3D models
  • Majid Al Futtaim is a branding partner for world-class fashion and retail brands with more than 100 stores across the Middle East and North Africa region
  • Nextech AR now supplies 3D models for Procter & Gamble, an S&P 500 company and Bunnings, the largest  retailer of home improvement supplies in Australia and New Zealand
  • Nextech AR Solutions is a metaverse company active in augmented reality, 3D modelling, holograms and 360° portals
  • Nextech (NTAR) opened trading at C$0.90

Nextech AR Solutions Corp. (NTAR) announced an expansion contract supplying thousands of 3D model products for Majid Al Futtaim.

Nextech AR also announced that it now supplies 3D models for Procter & Gamble, an S&P 500 company and Bunnings, the largest retailer of home improvement supplies in Australia and New Zealand.

These 3D modelling contracts are further evidence of the global demand for 3D models. Nextech anticipates the 3D model trend gaining even more traction in 2023 as the mass adoption of 3D models continues.

Nextech is currently in discussions with other major retailers and is anticipating a record number of new deals for 3D models in 2023.

Nextech AR has recently signed contracts for a variety of industries, including specialty products, specialty outdoor furniture, sports equipment, furniture and home goods.

Nextech AR Solutions is a metaverse company active in augmented reality, 3D modelling, holograms and 360° portals.

Nextech AR Solutions (NTAR) opened trading at C$0.90.



More From The Market Online

@ the Bell: TSX powers through to close week higher

Canada’s main stock index inched up on Friday. The only drag on the TSX was a drop in the energy sector while mining led…

Tilray’s 10 Barrel Brewing introduces new Mexican-style lagers

Tilray Brands (TSX:TLRY) subsidiary 10 Barrel Brewing unveils its latest creation: Pub Cerveza, a southern spirit in a Mexican-style lager.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.